Stryker Co. (NYSE:SYK) Shares Acquired by Capital Investment Services of America Inc. – Riverton Roll

Capital Investment Services of America Inc. grew its stake in shares of Stryker Co. (NYSE:SYK) by 0.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 93,060 shares of the medical technology companys stock after purchasing an additional 381 shares during the period. Stryker comprises approximately 2.6% of Capital Investment Services of America Inc.s portfolio, making the stock its 14th biggest position. Capital Investment Services of America Inc.s holdings in Stryker were worth $19,537,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Ossiam bought a new position in shares of Stryker in the second quarter worth $33,000. Garrett Wealth Advisory Group LLC bought a new position in shares of Stryker in the third quarter worth $35,000. Stonebridge Capital Advisors LLC bought a new position in shares of Stryker in the second quarter worth $39,000. Evoke Wealth LLC bought a new position in shares of Stryker in the third quarter worth $42,000. Finally, Horan Capital Advisors LLC. bought a new position in shares of Stryker in the third quarter worth $43,000. 73.24% of the stock is owned by hedge funds and other institutional investors.

SYK has been the topic of several research analyst reports. Piper Sandler cut Stryker from an overweight rating to a neutral rating and set a $210.00 target price on the stock. in a research note on Tuesday, January 7th. Deutsche Bank initiated coverage on Stryker in a research note on Friday, January 3rd. They issued a buy rating and a $179.00 target price on the stock. Barclays lowered shares of Stryker from an overweight rating to an equal weight rating and cut their price target for the company from $226.00 to $207.00 in a research report on Tuesday, November 5th. SunTrust Banks initiated coverage on shares of Stryker in a research report on Tuesday, January 7th. They set a hold rating and a $217.00 price target for the company. Finally, Morgan Stanley upped their price target on shares of Stryker from $230.00 to $242.00 and gave the company an overweight rating in a research report on Tuesday, December 17th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $222.16.

SYK traded down $1.99 on Friday, hitting $214.23. The company had a trading volume of 1,556,418 shares, compared to its average volume of 1,255,669. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.18 and a quick ratio of 1.35. Stryker Co. has a 52-week low of $160.79 and a 52-week high of $223.45. The stock has a fifty day simple moving average of $208.64 and a 200-day simple moving average of $211.33. The firm has a market capitalization of $80.89 billion, a P/E ratio of 23.75, a P/E/G ratio of 2.41 and a beta of 0.76.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $1.91 EPS for the quarter, topping the Thomson Reuters consensus estimate of $1.90 by $0.01. Stryker had a net margin of 23.55% and a return on equity of 25.33%. The business had revenue of $3.59 billion during the quarter, compared to analyst estimates of $3.58 billion. During the same period last year, the business posted $1.69 earnings per share. Strykers quarterly revenue was up 10.6% compared to the same quarter last year. Equities research analysts expect that Stryker Co. will post 8.23 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.575 per share. This is an increase from Strykers previous quarterly dividend of $0.52. The ex-dividend date is Monday, December 30th. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.07%. Strykers dividend payout ratio (DPR) is currently 31.46%.

In other Stryker news, COO Timothy J. Scannell sold 4,666 shares of the firms stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $206.28, for a total transaction of $962,502.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin Lobo sold 19,286 shares of the firms stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $215.71, for a total transaction of $4,160,183.06. The disclosure for this sale can be found here. Insiders have sold 26,652 shares of company stock valued at $5,705,481 in the last ninety days. Insiders own 7.20% of the companys stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: Liquidity

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

Read more:
Stryker Co. (NYSE:SYK) Shares Acquired by Capital Investment Services of America Inc. - Riverton Roll